Showing results (61-70 of 676) with videos related to
Sort By:
Pageof 68
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Immunosuppressive agents in multiple sclerosisOliver Neuhaus, Bernd C Kieseier, Hans-Peter HartungTrends in Pharmacological Sciences|March 12, 2003
Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotectionOliver Neuhaus, Juan J Archelos, Hans-Peter HartungBiological Research|October 22, 2005
Tissue mRNA expression in rat of newly described matrix metalloproteinasesFabian Bernal, Hans-Peter Hartung, Bernd C KieseierJournal of Neurology|October 29, 2005
Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosisHans-Peter Hartung, Bernd C Kieseier, Bernhard HemmerBrain : a Journal of Neurology|July 1, 2022
Contribution of B cells to cortical damage in multiple sclerosisPavan Bhargava, Hans-Peter Hartung, Peter A CalabresiExpert Review of Neurotherapeutics|April 28, 2005
Mitoxantrone (Novantrone) in multiple sclerosis: new insightsOliver Neuhaus, Bernd C Kieseier, Hans-Peter HartungMuscle & Nerve|April 4, 2006
Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseasesChristiane Schneider-Gold, Hans-Peter Hartung, Ralf GoldJournal of the Neurological Sciences|July 21, 2004
Mechanisms of mitoxantrone in multiple sclerosis--what is known?Oliver Neuhaus, Bernd C Kieseier, Hans-Peter HartungCNS Drugs|July 12, 2018
Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and BeyondVerena Isabell Leussink, Xavier Montalban, Hans-Peter HartungBrain : a Journal of Neurology|April 22, 2011
Enhancing remyelination in disease--can we wrap it up?Mark R Kotter, Christine Stadelmann, Hans-Peter HartungPageof 68